Glucagon like peptide 1 (GLP-1) based therapies are now widely used for the treatment of type 2 diabetes. only a small chromanol sensitive current that might be attributable to KCNQ1. GLP-1 release from main L-cells is usually linked to electrical activity and activation of L-type and Q-type calcium currents. The concept of an electrically excitable… Continue reading Glucagon like peptide 1 (GLP-1) based therapies are now widely used